Investigational dopamine antagonists for the treatment of schizophrenia.

about

Current Concepts and Treatments of Schizophrenia Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1-indole (D2AAK1_3) as Dopamine D₂ Receptor Ligand

P2860

Q58693044-9E995A57-92C5-4B9D-AD68-3F5B8FEBD0AC Q58696209-2E4A541B-AC7C-406B-9855-B69D91EECF0F

P2860

Investigational dopamine antagonists for the treatment of schizophrenia.

Item

http://www.wikidata.org/entity/Q36356306

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Investigational dopamine antagonists for the treatment of schizophrenia.

@ast

Investigational dopamine antagonists for the treatment of schizophrenia.

@en

type

Item

label

Investigational dopamine antagonists for the treatment of schizophrenia.

@ast

Investigational dopamine antagonists for the treatment of schizophrenia.

@en

prefLabel

Investigational dopamine antagonists for the treatment of schizophrenia.

@ast

Investigational dopamine antagonists for the treatment of schizophrenia.

@en

P1476

Investigational dopamine antagonists for the treatment of schizophrenia.

@en

P2093

Ashwin A Patkar

http://www.w3.org/2001/XMLSchema#string

Changsu Han

http://www.w3.org/2001/XMLSchema#string

Chi-Un Pae

http://www.w3.org/2001/XMLSchema#string

Prakash S Masand

http://www.w3.org/2001/XMLSchema#string

Sheng-Min Wang

http://www.w3.org/2001/XMLSchema#string

Soo-Jung Lee

http://www.w3.org/2001/XMLSchema#string

Tae-Youn Jun

http://www.w3.org/2001/XMLSchema#string

P2860

The dopamine hypothesis of schizophrenia: version III--the final common pathway

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Rethinking schizophrenia

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

Amisulpride: a review of its use in the management of schizophrenia

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

P304

687-698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2017.1323870

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28443355

http://www.w3.org/2001/XMLSchema#string

P921

dopamine

schizophrenia

Investigational dopamine antagonists for the treatment of schizophrenia.

about

P2860

P2860

Investigational dopamine antagonists for the treatment of schizophrenia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921